At this time, all the big names have solid fellowship programs.
My advice is to ask very carefully how many patients are being treated with AAT, make certain both meds are being used. Places like Wash U, Stanford, MGH, Yale, U Penn, Mayo have worked up and dosed hundreds of patients, others are lagging. If you end up at a place with low volume, then you'll screw yourself. For example, I've been told that UCSF has a lot of internal hurdles and basically sends patients to Sutter Health. I think the NYC region is underserved for the same reason: big institutions, big self generated hurdles.
For example, I've been told that UCSF has a lot of internal hurdles and basically sends patients to Sutter Health. I think the NYC region is underserved for the same reason: big institutions, big self generated hurdles.